arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1912.06381q-bio.TOnlin.AO
收藏

化疗条件下血管化肿瘤的演化动力学

Evolutionary dynamics in vascularised tumours under chemotherapy

Chiara Villa, Mark A. J. Chaplain, Tommaso Lorenzi

摘要:

我们考虑一个数学模型的演化动力学的肿瘤细胞在血管化肿瘤化疗。该模型包括一个系统的耦合偏积分微分方程的肿瘤细胞的表型分布,氧的浓度和化疗剂的浓度。为了解开不同的进化参数对肿瘤内表型异质性的出现和对化疗的耐药性的发展的影响,我们构建了明确的解决方案,肿瘤细胞的表型分布方程,并提供了详细的定量表征,这种解决方案的长期渐近行为。将分析结果与基于生物学一致参数值的模型的校准版本的数值模拟相结合。所获得的结果提供了一个理论解释的观察,即在血管化的肿瘤中的肿瘤细胞的表型特性随距离血管。此外,我们证明,较低的氧水平可能与较高水平的表型变异性,这表明缺氧区域的存在支持肿瘤内表型异质性。最后,我们的分析结果提出了一个严格的数学基础的想法,以前提出的正式渐近结果和数值模拟,缺氧有利于选择化疗耐药表型变异体治疗前。因此,这促进了化疗后耐药性的发展。

英文摘要:

We consider a mathematical model for the evolutionary dynamics of tumour cells in vascularised tumours under chemotherapy. The model comprises a system of coupled partial integro-differential equations for the phenotypic distribution of tumour cells, the concentration of oxygen and the concentration of a chemotherapeutic agent. In order to disentangle the impact of different evolutionary parameters on the emergence of intra-tumour phenotypic heterogeneity and the development of resistance to chemotherapy, we construct explicit solutions to the equation for the phenotypic distribution of tumour cells and provide a detailed quantitative characterisation of the long-time asymptotic behaviour of such solutions. Analytical results are integrated with numerical simulations of a calibrated version of the model based on biologically consistent parameter values. The results obtained provide a theoretical explanation for the observation that the phenotypic properties of tumour cells in vascularised tumours vary with the distance from the blood vessels. Moreover, we demonstrate that lower oxygen levels may correlate with higher levels of phenotypic variability, which suggests that the presence of hypoxic regions supports intra-tumour phenotypic heterogeneity. Finally, the results of our analysis put on a rigorous mathematical basis the idea, previously suggested by formal asymptotic results and numerical simulations, that hypoxia favours the selection for chemoresistant phenotypic variants prior to treatment. Consequently, this facilitates the development of resistance following chemotherapy.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑